Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,056 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients.
Piciocchi A, Cipriani M, Messina M, Marconi G, Arena V, Soddu S, Crea E, Feraco MV, Ferrante M, La Sala E, Fazi P, Buccisano F, Voso MT, Martinelli G, Venditti A, Vignetti M. Piciocchi A, et al. Among authors: messina m. EJHaem. 2024 Mar 15;5(2):353-359. doi: 10.1002/jha2.873. eCollection 2024 Apr. EJHaem. 2024. PMID: 38633115 Free PMC article.
The COVID-19 pandemic and management of GIMEMA clinical trials: changes and challenges.
Piciocchi A, Messina M, Soddu S, La Sala E, Paoloni F, Giuliani G, Marino MR, Petrelli C, Gorreo Renzulli L, Fazi P, Vignetti M. Piciocchi A, et al. Among authors: messina m. Br J Haematol. 2020 Aug;190(4):e211-e214. doi: 10.1111/bjh.16996. Epub 2020 Jul 26. Br J Haematol. 2020. PMID: 32621754 Free PMC article. No abstract available.
Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol.
Messina M, Piciocchi A, Ottone T, Paolini S, Papayannidis C, Lessi F, Fracchiolla NS, Forghieri F, Candoni A, Mengarelli A, Martelli MP, Venditti A, Carella AM, Albano F, Mancini V, Massimo B, Arena V, Sargentini V, Sciumè M, Pastore D, Todisco E, Roti G, Siragusa S, Ladetto M, Pravato S, De Bellis E, Simonetti G, Marconi G, Cerchione C, Fazi P, Vignetti M, Amadori S, Martinelli G, Voso MT. Messina M, et al. Cancers (Basel). 2022 Jun 18;14(12):3012. doi: 10.3390/cancers14123012. Cancers (Basel). 2022. PMID: 35740677 Free PMC article.
Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996.
Piciocchi A, Messina M, Elia L, Vitale A, Soddu S, Testi AM, Chiaretti S, Mancini M, Albano F, Spadano A, Krampera M, Bonifacio M, Cairoli R, Vetro C, Colella F, Ferrara F, Cimino G, Bassan R, Fazi P, Vignetti M. Piciocchi A, et al. Among authors: messina m. Am J Hematol. 2021 Sep 1;96(9):E334-E338. doi: 10.1002/ajh.26253. Epub 2021 Jun 9. Am J Hematol. 2021. PMID: 34048072 Free article. Clinical Trial. No abstract available.
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial.
Testi AM, Canichella M, Vitale A, Piciocchi A, Guarini A, Starza ID, Cavalli M, De Propris MS, Messina M, Elia L, Moleti ML, Martino B, Luppi M, D'Aloisio M, Candoni A, Conter V, Fazi P, Vignetti M, Chiaretti S, Foà R. Testi AM, et al. Among authors: messina m. Am J Hematol. 2021 Mar 1;96(3):292-301. doi: 10.1002/ajh.26066. Epub 2020 Dec 29. Am J Hematol. 2021. PMID: 33284999 Free article. Clinical Trial.
Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia.
Fazio F, Cunsolo G, Mancini F, De Propris MS, Piciocchi A, Arena V, Messina M, Ansuinelli M, Taherinasab AT, Apicella V, Vitale A, Chiaretti S, Guarini A, Del Giudice I, Foà R. Fazio F, et al. Among authors: messina m. Leuk Lymphoma. 2022 Jun;63(6):1512-1514. doi: 10.1080/10428194.2022.2032035. Epub 2022 Feb 8. Leuk Lymphoma. 2022. PMID: 35133227 No abstract available.
Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine.
Breccia M, Piciocchi A, Messina M, Soddu S, De Stefano V, Bellini M, Iurlo A, Martino B, Siragusa S, Albano F, Mora B, Fazi P, Vignetti M, Guglielmelli P, Palandri F. Breccia M, et al. Among authors: messina m. Leukemia. 2022 Oct;36(10):2548-2550. doi: 10.1038/s41375-022-01675-1. Epub 2022 Aug 13. Leukemia. 2022. PMID: 35963940 Free PMC article. No abstract available.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Mauro FR, Starza ID, Messina M, Reda G, Trentin L, Coscia M, Sportoletti P, Orsucci L, Arena V, Casaluci GM, Marasca R, Murru R, Laurenti L, Ilariucci F, Stelitano C, Mannina D, Massaia M, Rigolin GM, Scarfò L, Marchetti M, Levato L, Tani M, Arcari A, Musuraca G, Deodato M, Galieni P, Patrizi VB, Gottardi D, Liberati AM, Giordano A, Molinari MC, Pietrasanta D, Mattiello V, Visentin A, Vitale C, Albano F, Neri A, De Novi LA, De Propris MS, Nanni M, Del Giudice I, Guarini A, Fazi P, Vignetti M, Piciocchi A, Cuneo A, Foà R. Mauro FR, et al. Among authors: messina m. Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116. Haematologica. 2023. PMID: 36632738 Free PMC article. Clinical Trial.
Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey.
Breccia M, Piciocchi A, Abruzzese E, Cilloni D, Messina M, Soddu S, Castagnetti F, Stagno F, Fazi P, Iurlo A, Caocci G, Gozzini A, Intermesoli T, D'Adda M, Pane F. Breccia M, et al. Among authors: messina m. J Clin Med. 2023 Aug 13;12(16):5267. doi: 10.3390/jcm12165267. J Clin Med. 2023. PMID: 37629308 Free PMC article.
1,056 results